Tenofovir alafenamide-tafnat (25 mg)

NATCO PHARMA LIMITED (INDIA)

“Tenofovir Alafenamide” is the Drug / Molecule content in “Tafnat”. Tenofovir alafenamide is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) and a novel ester prodrug of the antiretroviral. Tenofovir alafenamide mimics normal DNA building blocks but is lacking a 3′-OH molecule required for phosphodiester bond linkage. Tenofovir alafenamide causes early chain termination and prevents proviral DNA 27 transcription.

Category:

Indication

Tenofovir alafenamide is used in the treatment of HIV infection and Chronic hepatitis B.

Note

Precaution

  • Tenofovir alafenamide is a prescription drug and should be used under proper medical guidance and advice.
  • Treatment with Tenofovir alafenamide should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity .

Related products